The Recent 7.2% Gain Must Have Brightened CEO Ruiqiang Li's Week, Novogene Co., Ltd.'s (SHSE:688315) Most Bullish Insider
The Recent 7.2% Gain Must Have Brightened CEO Ruiqiang Li's Week, Novogene Co., Ltd.'s (SHSE:688315) Most Bullish Insider
Key Insights
主要見解
- Significant insider control over Novogene implies vested interests in company growth
- 53% of the company is held by a single shareholder (Ruiqiang Li)
- Institutional ownership in Novogene is 16%
- Novogene股權中有重要內部控制,意味着對公司增長有着既得利益
- 該公司的53%股份由單一股東(Ruiqiang Li)持有
- Novogene的機構所有權爲16%
A look at the shareholders of Novogene Co., Ltd. (SHSE:688315) can tell us which group is most powerful. We can see that individual insiders own the lion's share in the company with 53% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
看一下Novogene Co., Ltd.(SHSE:688315)的股東,我們就能判斷哪個群體最具影響力。我們可以看到,個人內部持有公司的大部分股權,佔有53%。換句話說,這個群體將從他們對公司的投資中獲得最大利益(或蒙受最大損失)
As a result, insiders scored the highest last week as the company hit CN¥5.6b market cap following a 7.2% gain in the stock.
作爲結果,在公司股票上漲7.2%後,內部人員上週得分最高,市值達到了56億人民幣。
In the chart below, we zoom in on the different ownership groups of Novogene.
在下面的圖表中,我們關注諾禾基因的不同所有權群體。

What Does The Institutional Ownership Tell Us About Novogene?
機構持有權告訴我們關於諾禾基因的什麼?
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
機構投資者通常將自己的回報與常見的指數回報進行比較。因此,他們通常會考慮購買包括在相關基準指數中的較大公司。
We can see that Novogene does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Novogene, (below). Of course, keep in mind that there are other factors to consider, too.
我們看到諾禾基因確實有機構投資者;他們持有公司股票的很大一部分。這可能表明公司在投資社區中享有一定的可信度。然而,最好謹慎依賴機構投資者所帶來的所謂驗證。有時,他們也會做出錯誤的判斷。如果兩家大型機構投資者同時試圖拋售一隻股票,股價大幅下跌並非罕見。所以值得檢查諾禾基因的過去收入軌跡(如下)。當然,也要記得考慮其他因素。

Novogene is not owned by hedge funds. Looking at our data, we can see that the largest shareholder is the CEO Ruiqiang Li with 53% of shares outstanding. This implies that they possess majority interests and have significant control over the company. Investors usually consider it a good sign when the company leadership has such a significant stake, as this is widely perceived to increase the chance that the management will act in the best interests of the company. Meanwhile, the second and third largest shareholders, hold 12% and 4.5%, of the shares outstanding, respectively.
華大基因不是由對沖基金持有。根據我們的數據,最大的股東是CEO李瑞強,持有53%的流通股。這意味着他們擁有絕大多數利益,並對公司有着重大控制權。投資者通常認爲,當公司領導層持有如此大比例的股份時,這是一個良好的跡象,因爲普遍認爲這會增加管理層爲公司利益而行事的機會。與此同時,第二和第三大股東分別持有流通股的12%和4.5%。
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.
雖然研究一個公司的機構持股數據是有意義的,但研究分析師預期增長也是有意義的,因爲很多分析師都有關注這些股票,因此可以很容易地了解預期增長。
Insider Ownership Of Novogene
華大基因的內部持股情況
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
雖然內部人員的具體定義可能是主觀的,但幾乎所有人都認爲董事會成員是內部人員。公司管理層應向董事會回答問題,後者應代表股東的利益。值得注意的是,有時高層管理人員也會成爲董事會成員。
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
大多數人認爲內部所有權是積極的,因爲它可以表示董事會與其他股東的利益相一致。但是,在某些場合下,這個團體的權力過於集中。
Our most recent data indicates that insiders own the majority of Novogene Co., Ltd.. This means they can collectively make decisions for the company. That means they own CN¥3.0b worth of shares in the CN¥5.6b company. That's quite meaningful. It is good to see this level of investment. You can check here to see if those insiders have been buying recently.
我們最近的數據顯示,內部持有人擁有Novogene Co.,Ltd.的大部分股份。這意味着他們可以共同爲公司做出決定。這意味着他們擁有價值30億人民幣的股份,佔總市值56億人民幣的公司的很大部分。這是非常有意義的。看到這種投資水平是很好的。您可以在這裏查看是否這些內部持有人最近一直在買入。
General Public Ownership
一般大衆所有權
With a 17% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Novogene. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
一般公衆擁有17%的股份,主要由個人投資者組成,在Novogene上有一定的影響力。儘管這一持股比例相當可觀,但如果決定與其他大股東不同步,可能不足以改變公司政策。
Private Company Ownership
私有公司的所有權
We can see that Private Companies own 15%, of the shares on issue. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.
我們可以看到,私營企業擁有發行股票的15%。私營企業可能是相關方。有時,內部人通過持有私人公司的股份而不是以個人身份擁有對公開公司的利益。雖然很難得出任何廣泛的結論,但作爲進一步研究的領域值得注意。
Next Steps:
下一步:
While it is well worth considering the different groups that own a company, there are other factors that are even more important.
雖然考慮所有擁有一家公司的群體很重要,但還有其他更重要的因素。
Many find it useful to take an in depth look at how a company has performed in the past. You can access this detailed graph of past earnings, revenue and cash flow.
很多人覺得深入了解一家公司過去的表現是有用的。您可以訪問此詳細的過去收益、營業收入和現金流量圖。
But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.
但最終,決定該業務所有者將獲得多大利益的是未來而非過去。因此,我們認爲最好查看此免費報告,以了解分析師是否預測更光明的未來。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。